 ATLANTA, Sept. 20, 2021 GLOBE NEWSWIRE -- Femasys Inc. NASDAQ: FEMY Femasys or the Company, a biomedical company developing a suite of product candidates to transform womens healthcare with minimally invasive, non-surgical, in-office technologies, announced that the Company has been added to the Russell Microcap Index today when the U.S. market opened. The Russell Microcap Index is widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately 10.6 trillion in assets are benchmarked against Russells US indexes. Russell indexes are part of FTSE Russell, a leading global index provider. 